3 unknown. .
Follow Berry Genomics Co., Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparative Genomic Profiling of Lung Adenocarcinoma in Asians and Caucasians: A Propensity Matched Analysis Adenocarcinoma of Lung | Unknown | Jun Wang | 450 | 2021-01-01 | 2021-01-05 | |
| A Prospective Study to Evaluate the Consistency of Next-Generation Sequencing(NGS)-Panels by Using Malignant Hydrothorax Form NSCLC in vitro NGS-panel - Malignant Hydrothorax, NSCLC | Unknown | Shanghai Chest Hospital | 50 | 2018-05-18 | 2018-06-07 | |
| cSMART Liquid Biopsy and Dynamic Monitor of NSCLC Patients in Inner-Mongolia China Nonsmall Cell Lung Cancer, Adenocarcinoma | Unknown | Berry Genomics Co., Ltd. | 129 | 2016-11-01 | 2018-07-11 |
Adenocarcinoma (1) · Adenocarcinoma of Lung (1) · Carcinoma, Non-Small-Cell Lung (1)
China (2)
Shun Lu, MD/PhD (1)